Citation Impact
Citing Papers
Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study
2005
Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2
2009 Standout
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer
2002
High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
2005
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Advanced stage clear-cell epithelial ovarian cancer: The Hellenic cooperative oncology group experience
2006
Endometriosis and the development of malignant tumours of the pelvis. A review of literature
2004
Dopamine Resistance of Prolactinomas
2003
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ovarian cancer
2014 Standout
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
2001 Standout
Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?
1992
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Gestational trophoblastic disease
2010 Standout
Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma.
1998
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Cumulative toxicities from cisplatin therapy and current cytoprotective measures
1998
Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents
1988
Intravenous Nutritional Support during Pregnancy
1988
A systematic review of the global prevalence of low back pain
2012 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
2006
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer
2002
Advanced stage mucinous epithelial ovarian cancer: The Hellenic Cooperative Oncology Group experience
2005
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Developmental chemotherapy in advanced ovarian cancer: Incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182)
2002
Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole
2010 Standout
Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary
2009
Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgery
1992
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: A Gynecologic Oncology Group study
2008
INTRAVENOUS vs INTRAPERITONEAL SENSITIZER: IMPLICATIONS FOR INTRAPERITONEAL PHOTODYNAMIC THERAPY
1991
Current management of gestational trophoblastic diseases
2008
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
1991
Infectious and immunosuppressive complications of purine analog therapy.
1995
Surveillance Procedures for Patients for Cervical Carcinoma: A Review of the Literature
2009
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms
2012
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.
1997
Cisplatin: The first metal based anticancer drug
2019 Standout
Endometriosis
2004 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients A Hellenic Cooperative Oncology Group Study
2003
Lymphedema beyond breast cancer
2010 Standout
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer
2004
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Endometriosis: pathogenesis and treatment
2013 Standout
Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery
2015
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma
1991
Endometrial cancer
1997
Musculoskeletal Aspects of Pregnancy
2005 Standout
Cervical cancer
2019 Standout
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered
1992
Gestational trophoblastic tumors
1990
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Musculoskeletal Disorders of Pregnancy, Delivery and Postpartum
2007
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer
2003
Cancer of the Ovary
2004 Standout
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Low concentrations of dopamine increase cytosolic calcium in lactotrophs.
1993
Second-Line Treatment of Ovarian Cancer
2000
Granulosa Cell Tumor of the Ovary
2003
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Review: Practical considerations in ovarian cancer chemotherapy
2010
Clinical characteristics of clear cell carcinoma of the ovary
2000
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia
1989
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
1996 Standout
The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
1992
Chemotherapy for Advanced Epithelial Ovarian Cancer
1992
Primary Vaginal Cancer
1998
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Randomized Controlled Trial of Single-Agent Paclitaxel Versus Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Recurrent Ovarian Cancer Who Responded to First-Line Platinum-Based Regimens
2002
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Pegylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer
2005
Review and Update
2003 Standout
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
2009 Standout
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
2016
Stimulation of prolactin release by dopamine withdrawal: role of membrane hyperpolarization
1994
Works of C. Allen Stringer being referenced
Postoperative Adjuvant Cisplatin, Doxorubicin, and Cyclophosphamide (PAC) Chemotherapy in Women with High-Risk Endometrial Carcinoma
1994
Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva
1990
Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer
2002
Clear cell carcinoma of the ovary: A study of 59 cases
1989
A Phase I/II Dose Escalation Study of Carboplatin in the Treatment of Newly Diagnosed Patients With Advanced Ovarian Cancer Receiving Paclitaxel
1999
High-risk metastatic gestational trophoblastic disease: Further stratification into two clinical entities
1989
Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamide
1989
Recurrent cervical carcinoma after radical hysterectomy
1988
Pharmacologic Evidence that a D2 Receptor Subtype Mediates Dopaminergic Stimulation of Prolactin Secretion from the Anterior Pituitary Gland
1991
Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: Tolerance and toxicity
1988
Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamide
1991
Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting.
1997
Secondary cytoreductive surgery for recurrent epithelial ovarian cancer
1989
Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysis
1990
Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide.
1987
Phase II trial of fludarabine in patients with epithelial ovarian cancer.
1986
Phase I study of topotecan (T) with carboplatin (C) alternating with paclitaxel (P) via 3 hour infusion with carboplatin (C) in treatment of newly diagnosed ovarian cancer (OC)
1999
Sarcoma botryoides of the female genital tract.
1985
Fetal growth sustained by parenteral nutrition in pregnancy.
1984
Diagnosis of recurrent cervical carcinoma after radical hysterectomy.
1988
Postpartum Osteitis Pubis
1985
Pazopanib (GW786034) is active in women with advanced epithelial ovarian, fallopian tube and peritoneal cancers: Initial results of a phase II study
2007
Alveolar rhabdomyosarcoma of the female genitalia
1985
Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy.
1989